Joby Aviation: Held Back By Untimely Capital Raises

Joby Aviation is trading at $7 and is described as deeply undervalued despite progress toward eVTOL certification and air-taxi launch. The article flags a potential $750M ATM capital raise tied to the $500M Resonant Sciences acquisition (with a $100M+ revenue defense unit), which pressures the stock in the near term. Offsetting catalysts include eIPP services in Dallas–Fort Worth and Dubai, alongside an $2B revenue target by 2030.

Analysis

The stock’s immediate setup is a financing event, not an operating one: any announced ATM is likely to cap upside in the next few sessions because the market will discount dilution before it prices in optionality. That said, a capital raise tied to a defense acquisition can be constructive if it materially extends runway without forcing a distressed price; for a pre-scale platform, the relevant question is not headline dilution but whether the proceeds buy enough time to reach certification milestones before the market demands proof.

The more interesting second-order effect is that a defense-oriented revenue stream can change the investor base. It broadens the story from a pure consumer mobility bet to a dual-use aerospace asset, which could attract strategic capital and lower the equity risk premium over 6-18 months. It also pressures the rest of the eVTOL cohort: if JOBY demonstrates a non-passenger revenue bridge, names like ACHR may face multiple compression because the sector has been valued as if all upside depends on one regulatory path.

Near term, the key risk is that the market treats the raise as a signal of hidden burn rather than strategic flexibility. What would reverse the bullish case is either a larger-than-expected capital need, a slip in certification timing, or no evidence that the new unit contributes meaningful gross margin within 1-3 quarters. The contrarian read is that the consensus may be overweighting dilution and underweighting runway; if management can show non-dilutive strategic demand, the stock can re-rate even before commercial launch economics are proven.

Key Decisions for Investors

• Hold off on initiating fresh long exposure until the financing terms are disclosed; if the raise is executed at a modest discount and extends runway by 12+ months, use the post-print weakness to build a starter long in JOBY with a 6-18 month horizon.
• For relative value, consider a small JOBY/ACHR long-short pair over the next 1-3 months: long JOBY on dual-use diversification and certification progress, short ACHR as the higher-beta pure-play most exposed to sector multiple compression if dilution becomes the market’s focus.
• If JOBY gaps higher on a low-friction raise, fade the move with a put spread rather than outright shorting; the risk/reward is better for expressing the near-term dilution overhang while limiting squeeze risk into catalyst headlines.
• Set a hard watch level around any raise size materially above the rumored $750M; that would likely shift the story from strategic funding to balance-sheet stress and is a thesis breaker for a bullish position.
• Do not use TGT as a read-through here; there is no meaningful sector linkage, so keep the trade framed strictly around aerospace/regulatory execution and capital structure.